Clinical Characteristics of Gastrointestinal Lymphomas Associated with AIDS (GI-ARL) and the Impact of HAART

REFERENCES

• Maso LD, Franceschi S. Epidemiology of non-Hodgkin lymphomas and other haemolymphopoietic neoplasms in people with AIDS. Lancet Oncol. 2003;4:110–119.
   PubMed Web of Science ®Google Scholar
• Ziegler JL, Beckstead JA, Volberding PA, et al. Non-Hodgkin's lymphoma in 90 homosexual men. Relation to generalized lymphadenopathy and the acquired immuno-deficiency syndrome. N Engl J Med. 1984;311:565–570.
   PubMed Web of Science ®Google Scholar
• Levine AM. Acquired immunodeficiency syndrome-related lymphoma. Blood. 1992;80:8–20.
   PubMed Web of Science ®Google Scholar
• Wang CY, Snow JL, Su WP. Lymphoma associated with human immunodeficiency virus infection. Mayo Clin Proc. 1995;70:665–672.
   PubMed Web of Science ®Google Scholar
• Parente F, Rizzardini G, Cernuschi M, et al. Non-Hodgkin's lymphoma and AIDS: frequency of gastrointestinal involve-ment in a large Italian series. Scand J Gastroenterol. 1993;28:315–318.
   PubMed Web of Science ®Google Scholar
• Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998;338:853–860.
   PubMed Web of Science ®Google Scholar
• Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults. J Nat/ Cancer Inst. 2000;92:1823-1830.
   Google Scholar
• Grulich AE, Li Y, McDonald AM, et al. Decreasing rates of Kaposi's sarcoma and non-Hodgkin's lymphoma in the era of potent combination anti-retroviral therapy. AIDS. 200115: 629–633.
   Google Scholar
• Carrieri MP, Pradier C, Piselli P, et al. Reduced incidence of Kaposi's sarcoma and of systemic non-Hodgkin's lym-phoma in HIV-infected individuals treated with highly active antiretroviral therapy. Int J Cancer. 2003;103:142–144.
   PubMed Web of Science ®Google Scholar
• Gerard L, Galicier L, Maillard A, et al. Systemic non-Hodgkin lymphoma in HIV-infected patients with effective suppression of HIV replication: persistent occurrence but improved survival. J Acquir Immune Defic Syndr. 2002;30:478–484.
   PubMed Web of Science ®Google Scholar
• Antinori A, Cingolani A, Alba L, et al. Better response to chemotherapy and prolonged survival in AIDS-related lym-phomas responding to highly active antiretroviral therapy. AIDS. 2001;15:1483–1491.
   PubMed Web of Science ®Google Scholar
• Tam HK, Zhang ZF, Jacobson LP, et al. Effect of highly active antiretroviral therapy on survival among HIV-in-fected men with Kaposi sarcoma or non-Hodgkin lym-phoma. Int J Cancer. 2002;98:916–922.
   PubMed Web of Science ®Google Scholar
• Holkova B, Takeshita K, Cheng DM, et al. Effect of highly active antiretroviral therapy on survival in patients with AIDS-associated pulmonary Kaposi's sarcoma treated with chemotherapy. J Clin Oncol. 2001;19:3848–3851.
   PubMed Web of Science ®Google Scholar
• Chanan-Khan A, Holkova B, Dmopoulos R, et al. Changing epidemiology of AIDS related non-Hodgkin's lymphoma (ARL) in the era of highly active anti-retroviral therapy: experience at a municipal hospital in New York City. J Clin Oncol. 2002;21(1):289a.
   Google Scholar
• Koch P, del Valle F, Berdel WE, et al. Primary gastrointesti-nal non-Hodgkin's lymphoma: I. Anatomic and histologic distribution, clinical features, and survival data of 371 pa-tients registered in the German Multicenter Study GIT NHL 01/92. J Clin Oncol. 2001;19:3861–3873.
   PubMed Web of Science ®Google Scholar
• Crump M, Gospodarowicz M, Shepherd FA. Lymphoma of the gastrointestinal tract. Semin Oncol. 1999;26:324–337.
   PubMed Web of Science ®Google Scholar
• Kaplan EL, Meier P. Nonparametric estimation from incom-plete observations. J Am Statistics Assoc. 1958;53:457–486.
   Web of Science ®Google Scholar
• Imrie KR, Sawka CA, Kutas G, et al. HIV-associated lym-phoma of the gastrointestinal tract: the University of Toronto AIDS-Lymphoma Study Group experience. Leuk Lymphoma. 1995;16:343–349.
   PubMed Web of Science ®Google Scholar
• Heise W, Arasteh K, Mosteitz P, et al. Malignant gas-trointestinal lymphomas in patients with AIDS. Digestion. 1997;58:218–224.
   PubMed Web of Science ®Google Scholar
• Levine AM, Seneviratne L, Espina BM, et al. Evolving char-acteristics of AIDS-related lymphoma. Blood. 2000;96:4084–4090.
   PubMed Web of Science ®Google Scholar
• Gill PS, Levine AM, Krailo M, et al. AIDS-related malignant lymphoma: results of prospective treatment trials. J Clin Oncol. 1987;5:1322–1328.
   PubMed Web of Science ®Google Scholar
• Scadden DT. AIDS-related malignancies. Annu Rev Med. 2003;54:285–303.
   PubMed Web of Science ®Google Scholar
• Otter R, Bieger R, Kluin PM, et al. Primary gastrointestinal non-Hodgkin's lymphoma in a population-based registry. Br J Cancer. 1989;60:745–750.
   PubMed Web of Science ®Google Scholar
• d'Amore F, Brincker H, Gronbaek K, et al. Non-Hodgkin's lymphoma of the gastrointestinal tract: a population-based analysis of incidence, geographic distribution, clinico-pathologic presentation features, and prognosis. Danish Lymphoma Study Group. J Clin Oncol. 1994;12:1673-1684.
   PubMed Web of Science ®Google Scholar
• Straus DJ, Huang J, Testa MA, et al. Prognostic factors in the treatment of human immunodeficiency virus-associ-ated non-Hodgkin's lymphoma: analysis of AIDS Clinical Trials Group protocol 142—low-dose versus standard-dose m-BACOD plus granulocyte-macrophage colony-stimulating factor. National Institute of Allergy and Infec-tious Diseases. J Clin Oncol. 1998;16:3601–3606.
   PubMed Web of Science ®Google Scholar
• Straus DJ. Prognostic factors in the treatment of human immunodeficiency virus-associated non-Hodgkin's lym-phoma. Recent Results Cancer Res. 2002;159:143–148.
   PubMedGoogle Scholar